{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:04:56Z","timestamp":1790964296831,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA266446"],"award-info":[{"award-number":["R01CA266446"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA258829"],"award-info":[{"award-number":["R37CA258829"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA222663"],"award-info":[{"award-number":["K08CA222663"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA263381"],"award-info":[{"award-number":["R21CA263381"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["21-104-01-IBCD"],"award-info":[{"award-number":["21-104-01-IBCD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0C530N"],"award-info":[{"award-number":["G0C530N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G070622N"],"award-info":[{"award-number":["G070622N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004727","name":"Vlaams Instituut voor Biotechnologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["FAF-F\/2018\/1265"],"award-info":[{"award-number":["FAF-F\/2018\/1265"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000654","name":"Marie Curie","doi-asserted-by":"publisher","award":["896897"],"award-info":[{"award-number":["896897"]}],"id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000654","name":"Marie Curie","doi-asserted-by":"publisher","award":["H2020-MSCA-IF-2019"],"award-info":[{"award-number":["H2020-MSCA-IF-2019"]}],"id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ccell.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T18:54:49Z","timestamp":1686855289000},"page":"1207-1221.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity"],"prefix":"10.1016","volume":"41","author":[{"given":"Patricia","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meri","family":"Rogava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Frangieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Po\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivem B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Kyrysyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Dipak","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Caprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey R.","family":"Ager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Khosravi-Maharlooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hijab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel F.","family":"Bakhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantale","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai W.","family":"Wucherpfennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-6702","authenticated-orcid":false,"given":"Benjamin","family":"Izar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2023.05.014_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2023.05.014_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.05.014_bib6","doi-asserted-by":"crossref","first-page":"eabb0152","DOI":"10.1126\/scitranslmed.abb0152","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","volume":"12","author":"Kalbasi","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T\u00a0cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41588-021-00779-1","article-title":"Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion","volume":"53","author":"Frangieh","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.05.014_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41588-022-01268-9","article-title":"Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens","volume":"55","author":"Wang","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.05.014_bib10","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/eji.1830171227","article-title":"Purified lymphocyte function-associated antigen-3 and T11 target structure are active in CD2-mediated T\u00a0cell stimulation","volume":"17","author":"Tiefenthaler","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2023.05.014_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/323262a0","article-title":"Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones","volume":"323","author":"Shaw","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.165.3.677","article-title":"Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion","volume":"165","author":"Dustin","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/326400a0","article-title":"The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3","volume":"326","author":"Selvaraj","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/329840a0","article-title":"An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2","volume":"329","author":"Seed","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.166.4.923","article-title":"Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein","volume":"166","author":"Wallner","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cellsig.2009.02.022","article-title":"Signal transduction by CD58: the transmembrane isoform transmits signals outside lipid rafts independently of the GPI-anchored isoform","volume":"21","author":"Ariel","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ccell.2023.05.014_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cellsig.2003.08.015","article-title":"Distinct membrane localization and kinase association of the two isoforms of CD58","volume":"16","author":"Ariel","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ccell.2023.05.014_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2020-139605","article-title":"CD58 aberrations limit durable responses to CD19 CAR in large B cell lymphoma patients treated with axicabtagene ciloleucel but can be overcome through novel CAR engineering","volume":"136","author":"Majzner","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2023.05.014_bib19","article-title":"A TCF4\/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma","author":"Pozniak","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2023.05.014_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T\u00a0cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T\u00a0cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.181.1.429","article-title":"Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2","volume":"181","author":"Osborn","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1084\/jem.177.5.1439","article-title":"A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice","volume":"177","author":"Arulanandam","year":"1993","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.05.014_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib25","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.05.014_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2023.05.014_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1247\/csf.07045","article-title":"Human RME-8 is involved in membrane trafficking through early endosomes","volume":"33","author":"Fujibayashi","year":"2008","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ccell.2023.05.014_bib30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","article-title":"PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can Be targeted to sensitize to radiation or chemotherapy","volume":"74","author":"Tu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood.V75.9.1827.1827","article-title":"Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus","volume":"75","author":"Billaud","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2023.05.014_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/gcc.22276","article-title":"Alterations of the CD58 gene in classical Hodgkin lymphoma","volume":"54","author":"Schneider","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ccell.2023.05.014_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/gene.2016.30","article-title":"CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse","volume":"17","author":"Abdul Razak","year":"2016","journal-title":"Genes Immun."},{"key":"10.1016\/j.ccell.2023.05.014_bib35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41590-020-0770-x","article-title":"A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals","volume":"21","author":"Demetriou","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2023.05.014_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T\u00a0cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2023.05.014_bib37","doi-asserted-by":"crossref","first-page":"2200019","DOI":"10.1002\/adtp.202200019","article-title":"Dictating phenotype, function, and fate of human T\u00a0cells with Co-stimulatory antibodies presented by filamentous immune cell mimics","volume":"5","author":"Schluck","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ccell.2023.05.014_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1401917","article-title":"CD58\/CD2 is the primary costimulatory pathway in human CD28-CD8+ T\u00a0cells","volume":"195","author":"Leitner","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2023.05.014_bib39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ccell.2023.05.014_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aaf0683","article-title":"Rescue of exhausted CD8 T\u00a0cells by PD-1-targeted therapies is CD28-dependent","volume":"355","author":"Kamphorst","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ccell.2023.05.014_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41586-022-04439-0","article-title":"A trispecific antibody targeting HER2 and T\u00a0cells inhibits breast cancer growth via CD4 cells","volume":"603","author":"Seung","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib42","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/onc.2014.95","article-title":"CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer","volume":"34","author":"Xu","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2023.05.014_bib43","doi-asserted-by":"crossref","first-page":"1864909","DOI":"10.1080\/2162402X.2020.1864909","article-title":"Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy","volume":"10","author":"Martinez-Morilla","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ccell.2023.05.014_bib44","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jtho.2019.09.014","article-title":"Quantitative assessment of CMTM6 in the tumor microenvironment and association with response to PD-1 pathway blockade in advanced-stage non\u2013small cell lung cancer","volume":"14","author":"Zugazagoitia","year":"2019","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.ccell.2023.05.014_bib45","doi-asserted-by":"crossref","first-page":"e001638","DOI":"10.1136\/jitc-2020-001638","article-title":"CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer","volume":"9","author":"Peng","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2023.05.014_bib46","doi-asserted-by":"crossref","first-page":"585961","DOI":"10.3389\/fonc.2020.585961","article-title":"Prognostic implications of pan-cancer CMTM6 expression and its relationship with the immune microenvironment","volume":"10","author":"Zhao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2023.05.014_bib47","doi-asserted-by":"crossref","first-page":"eadd6403","DOI":"10.1126\/sciadv.add6403","article-title":"PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia","volume":"8","author":"Li","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2023.05.014_bib48","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR-Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2023.05.014_bib49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification-mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2023.05.014_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib51","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2023.05.014_bib52","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2023.05.014_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T\u00a0cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.05.014_bib54","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/s41467-018-07901-8","article-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","volume":"9","author":"Sanson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.05.014_bib55","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nbt.3026","article-title":"Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation","volume":"32","author":"Doench","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2023.05.014_bib56","series-title":"Toll-Like Receptors","first-page":"107","article-title":"Detection of interaction between toll-like receptors and other transmembrane proteins by Co-immunoprecipitation assay","author":"Lee","year":"2016"},{"key":"10.1016\/j.ccell.2023.05.014_bib57","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1074\/mcp.TIR118.000900","article-title":"Online parallel accumulation-serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer","volume":"17","author":"Meier","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ccell.2023.05.014_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2023.05.014_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ccell.2023.05.014_bib60","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ccell.2023.05.014_bib61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2023.05.014_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41592-020-01050-x","article-title":"Joint probabilistic modeling of single-cell multi-omic data with totalVI","volume":"18","author":"Gayoso","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2023.05.014_bib63","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2023.05.014_bib64","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.05.014_bib65","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.ccell.2023.05.014_bib66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2023.05.014_bib67","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823001812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823001812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:23:28Z","timestamp":1778617408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610823001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1535610823001812"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2023.05.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742685598.793600031","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}